Comparing the activation markers, regardless oftreatment, it was seen that the percentage of CD8+ HLADR+cells was lower in RA patients compared to controls, with a statisticaldifference of p < 0.05 (Figure 2). Here, CD8A is linked to rheumatoid arthritis.